“…Intramuscular and topical administration of triamcinolone, generally dispensed as the more potent acetonide derivative (16α,17α‐cyclic ketal or isopropylidene derivative), are successfully used for the treatment of dermatoses (2,3) and, in particular, of psoriasis (4,5), one of the few inflammatory dermatoses that does not respond to largely used topical steroids. Furthermore, this corticosteroid is used against drug‐induced erythema (6) and for the topical chemotherapy of pigment abnormalities in surgical patients (7). However, in this last application a moderate photoallergy has been noted, and, furthermore, it is known that this drug photobinds to the human mineralocorticoid receptor (8).…”